Helix Nanotechnologies YC 申请

Winter 2017Active

Helix Nanotechnologies 在 Winter 2017 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。

YC 批次: Winter 2017
行业: HealthcareDrug Discovery and Delivery
团队规模: 22
状态: Active
已发布: 2016

创始人

Nikolai EroshenkoFounder/CSO

Helix Nanotechnologies 做什么

Technology finds information and delivers physical products to us almost instantly. mRNA does the same for biology. At HelixNano, we see a world where treatments are cheap, progress is decentralized, and you can modify biology at the push of a button. By focusing on mRNA improvements from first principles, we’re getting there faster than we thought. Experiments that used to take months or years can be done in weeks and cost thousands instead of millions. The rate limiting step for our progress is now scientific curiosity. Rigid hierarchies and top-down decisions will miss the magic. Some of our most powerful technologies started out as side projects of junior team members. At HelixNano, every individual scientist can have a massive impact on the company's direction. And the more diverse our team, the faster we’ll find the really cool ideas. We've started rolling out some of our new tech - moving a COVID-19 vaccine candidate for the immunocompromised towards the clinic, and testing an intervention with massive environmental impact. But we’re scientists at heart, and team focus is solidly on the horizon.

Helix Nanotechnologies 的 YC 申请，重建版

Y Combinator 申请

Helix Nanotechnologies，Winter 2017 期。来自公开数据的真实申请问题解答。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Helix Nanotechnologies

Describe what your company does in 50 characters or less.

Next-generation mRNA platform for disease and climate

What is your company going to make? Please describe your product and what it does or will do.

We are building an mRNA platform that improves the speed and cost of developing therapies. Our technology allows experiments that once took months or years to be done in weeks, and for thousands of dollars instead of millions. We are advancing a COVID-19 vaccine candidate for the immunocompromised and testing an intervention aimed at climate impact.

Where do you live now, and where would the company be based after YC?

We live and work in Boston and Cambridge, MA, and will base the company there after YC.

Explain your decision regarding location.

Boston and Cambridge are biotech hubs with deep scientific talent and collaborators. Being here helps us attract the right team and stay on the cutting edge of RNA technology.

21 更多回答在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。

查看完整申请

常见问题解答

这是 Helix Nanotechnologies 的真实 YC 申请吗？

不是。Y Combinator 对提交的申请保密。这是重建版：使用 Helix Nanotechnologies 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 Helix Nanotechnologies 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。

Helix Nanotechnologies 是哪个 YC 批次的？

Helix Nanotechnologies 是 Y Combinator Winter 2017 批次的成员。

谁创立了 Helix Nanotechnologies？

Helix Nanotechnologies 由 Nikolai Eroshenko 创立。

Helix Nanotechnologies 做什么？

Next-generation mRNA platform to solve cancer, COVID and climate.

如何阅读完整的重建申请？

创建免费的 Round Funded 账户。YC Insights 中包含 Helix Nanotechnologies 的完整 26 个问题的版本，以及其他所有 YC 批次的公司信息。